Medtronic: Funding, Investors & Team (Sep 2026)
Medtronic develops healthcare technology to treat chronic diseases. Its medical technology is providing lifelong solutions for people with chronic pain. The company is committed to improving lives through its medical technologies, services, and solutions. Medtronic has four main business units: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States.
Medtronic has raised $3.5B across 1 funding round on record, the most recent a Post-IPO Debt of $3.5B announced in Sep 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Medtronic Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Medtronic Funding Rounds
Medtronic Founders and Leadership Team
No contact details are on record for this team yet.
Medtronic Funding Compared to Other Biotechnology Startups
Medtronic's latest round of $3.5B is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Medtronic in Biotechnology and Minneapolis
Companies Similar to Medtronic
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Medtronic Funding FAQs
What does Medtronic do?
Medtronic develops healthcare technology to treat chronic diseases. Its medical technology is providing lifelong solutions for people with chronic pain. The company is committed to improving lives through its medical technologies, services, and solutions. Medtronic has four main business units: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States.
How much funding has Medtronic raised?
Medtronic has raised $3.5B across 1 round on record. The most recent is a Post-IPO Debt of $3.5B announced in Sep 2022.
When did Medtronic last raise funding?
Medtronic's most recent funding round on record is a Post-IPO Debt of $3.5B, announced in Sep 2022.
Who is the CEO of Medtronic?
Geoffrey Martha is listed as CEO at Medtronic.
Where is Medtronic headquartered?
Medtronic is based in Minneapolis, Minnesota, United States.
How many employees does Medtronic have?
Medtronic is in the 5000+ employee band.
How does Medtronic's funding compare to other Biotechnology startups?
Medtronic's latest round of $3.5B is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Medtronic Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Medtronic is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.